AMP-activated protein kinase (AMPK)-induced preconditioning in primary cortical neurons involves activation of MCL-1

J Neurochem. 2013 Mar;124(5):721-34. doi: 10.1111/jnc.12108. Epub 2012 Dec 26.

Abstract

Neuronal preconditioning is a phenomenon where a previous exposure to a sub-lethal stress stimulus increases the resistance of neurons towards a second, normally lethal stress stimulus. Activation of the energy stress sensor, AMP-activated protein kinase (AMPK) has been shown to contribute to the protective effects of ischaemic and mitochondrial uncoupling-induced preconditioning in neurons, however, the molecular basis of AMPK-mediated preconditioning has been less well characterized. We investigated the effect of AMPK preconditioning using 5-aminoimidazole-4-carboxamide riboside (AICAR) in a model of NMDA-mediated excitotoxic injury in primary mouse cortical neurons. Activation of AMPK with low concentrations of AICAR (0.1 mM for 2 h) induced a transient increase in AMPK phosphorylation, protecting neurons against NMDA-induced excitotoxicity. Analysing potential targets of AMPK activation, demonstrated a marked increase in mRNA expression and protein levels of the anti-apoptotic BCL-2 family protein myeloid cell leukaemia sequence 1 (MCL-1) in AICAR-preconditioned neurons. Interestingly, over-expression of MCL-1 protected neurons against NMDA-induced excitotoxicity while MCL-1 gene silencing abolished the effect of AICAR preconditioning. Monitored intracellular Ca²⁺ levels during NMDA excitation revealed that MCL-1 over-expressing neurons exhibited improved bioenergetics and markedly reduced Ca²⁺ elevations, suggesting a potential mechanism through which MCL-1 confers neuroprotection. This study identifies MCL-1 as a key effector of AMPK-induced preconditioning in neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Adaptation, Physiological / physiology*
  • Aminoimidazole Carboxamide / analogs & derivatives
  • Aminoimidazole Carboxamide / pharmacology
  • Animals
  • Blotting, Western
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Flow Cytometry
  • Hypoglycemic Agents / pharmacology
  • Mice
  • Microscopy, Confocal
  • Myeloid Cell Leukemia Sequence 1 Protein
  • N-Methylaspartate / toxicity
  • Neurons / drug effects
  • Neurons / metabolism*
  • Protein Kinases / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Ribonucleotides / pharmacology
  • Stress, Physiological / physiology

Substances

  • Hypoglycemic Agents
  • Mcl1 protein, mouse
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proto-Oncogene Proteins c-bcl-2
  • Ribonucleotides
  • Aminoimidazole Carboxamide
  • N-Methylaspartate
  • Protein Kinases
  • AMP-Activated Protein Kinase Kinases
  • AICA ribonucleotide